Glenmede Trust’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-10
| Closed | -$30K | – | 2646 |
|
|
2016
Q2 | $30K | Sell |
10
-235
| -96% | -$705K | ﹤0.01% | 1756 |
|
|
2016
Q1 | $633K | Hold |
245
| – | – | ﹤0.01% | 852 |
|
|
2015
Q4 | $30K | Buy |
245
+235
| +2,350% | +$28.8K | ﹤0.01% | 1735 |
|
|
2015
Q3 | $87K | Hold |
10
| – | – | ﹤0.01% | 1413 |
|
|
2015
Q2 | $186K | Hold |
10
| – | – | ﹤0.01% | 1244 |
|
|
2015
Q1 | $207K | Hold |
10
| – | – | ﹤0.01% | 1237 |
|
|
2014
Q4 | $189K | Hold |
10
| – | – | ﹤0.01% | 1322 |
|
|
2014
Q3 | $252K | Hold |
10
| – | – | ﹤0.01% | 1107 |
|
|
2014
Q2 | $237K | Hold |
10
| – | – | ﹤0.01% | 1112 |
|
|
2014
Q1 | $351K | Hold |
10
| – | – | ﹤0.01% | 995 |
|
|
2013
Q4 | $369K | Hold |
10
| – | – | ﹤0.01% | 955 |
|
|
2013
Q3 | $515K | Hold |
10
| – | – | 0.01% | 806 |
|
|
2013
Q2 | $414K | Buy |
+10
| New | +$414K | 0.01% | 824 |
|